Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(11%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
33%
Ph phase_2
2
22%
Ph phase_1
2
22%
Ph phase_4
2
22%

Phase Distribution

2

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(5)
Other(1)

Detailed Status

Completed5
Not yet recruiting2
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (22.2%)
Phase 22 (22.2%)
Phase 42 (22.2%)
N/A3 (33.3%)

Trials by Status

not_yet_recruiting222%
recruiting111%
unknown111%
completed556%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9